Neovacs set for IPO
French biotech group Neovacs, backed by venture houses Truffle Capital and Novartis Venture Fund, is set to raise €20m from an initial public offering this month.
Founded
French biotech group Neovacs, backed by venture houses Truffle Capital and Novartis Venture Fund, is set to raise €20m from an initial public offering this month.
Founded